AbbVie, Inc. (ABBV)
287.08
-1.76
(-0.61%)
USD |
NYSE |
Nov 03, 14:22
AbbVie Market Cap : 507.29B for Nov. 3, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 02, 2026 | 510.40B |
| October 30, 2026 | 521.09B |
| October 29, 2026 | 513.85B |
| October 28, 2026 | 505.36B |
| October 27, 2026 | 506.07B |
| October 26, 2026 | 506.69B |
| October 23, 2026 | 504.75B |
| October 22, 2026 | 503.95B |
| October 21, 2026 | 503.26B |
| October 20, 2026 | 510.82B |
| October 19, 2026 | 499.52B |
| October 16, 2026 | 504.36B |
| October 15, 2026 | 500.79B |
| October 14, 2026 | 500.93B |
| October 13, 2026 | 484.81B |
| October 12, 2026 | 496.76B |
| October 09, 2026 | 488.54B |
| October 08, 2026 | 481.39B |
| October 07, 2026 | 479.51B |
| October 06, 2026 | 471.26B |
| October 05, 2026 | 469.62B |
| October 02, 2026 | 464.42B |
| October 01, 2026 | 459.31B |
| September 30, 2026 | 462.25B |
| September 29, 2026 | 465.25B |
| Date | Value |
|---|---|
| September 28, 2026 | 470.54B |
| September 25, 2026 | 467.11B |
| September 24, 2026 | 468.49B |
| September 23, 2026 | 468.41B |
| September 22, 2026 | 468.64B |
| September 21, 2026 | 467.35B |
| September 18, 2026 | 466.44B |
| September 17, 2026 | 466.54B |
| September 16, 2026 | 463.87B |
| September 15, 2026 | 464.81B |
| September 14, 2026 | 462.57B |
| September 11, 2026 | 454.35B |
| September 10, 2026 | 450.60B |
| September 09, 2026 | 443.38B |
| September 08, 2026 | 439.61B |
| September 04, 2026 | 453.18B |
| September 03, 2026 | 459.81B |
| September 02, 2026 | 462.48B |
| September 01, 2026 | 459.42B |
| August 31, 2026 | 453.11B |
| August 28, 2026 | 451.45B |
| August 27, 2026 | 456.17B |
| August 26, 2026 | 464.56B |
| August 25, 2026 | 469.67B |
| August 24, 2026 | 467.43B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 210.59B |
| Biogen, Inc. | 36.93B |
| Regeneron Pharmaceuticals, Inc. | 100.73B |
| Amgen, Inc. | 249.97B |
| REGENXBIO, Inc. | 407.31M |
Market Cap Related Metrics
| PE Ratio | 49.35 |
| PS Ratio | 7.709 |
| PEG Ratio | 0.1456 |
| Price | 287.08 |
| Earnings Yield | 2.03% |
| PEGY Ratio | 0.1445 |
| Operating PE Ratio | 21.28 |
| Normalized PE Ratio | 30.65 |